'Does anyone know where to get fits from around here' Policy implications for the provision of sterile injecting equipment through pharmacies in Sydney, Australia

Drugs: Education, Prevention and Policy

Volumn 17, Issue 1, 2010, Pages 72-83

  Treloar, Carla ^a   Hopwood, Max ^a   Bryant, Joanne ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 76149130751     PISSN: 09687637     EISSN: 14653370     Source Type: Journal    
DOI: 10.3109/09687630802067251     Document Type: Article

References (28)

1. Aitken, C., Moore, D., et al. (2002). The impact of a police crackdown on a street drug scene: Evidence from the street. International Journal of Drug Policy, 13, 189-198.
2. Bryant, J., & Treloar, C. (2006). Risk practices and other characteristics of injecting drug users who obtain injecting equipment from pharmacies and personal networks. International Journal of Drug Policy, 17, 418-424.
3. Burris, S., Blankenship, K., Donoghoe, M. C., Sherman, S. G., Vernick, J., Case, P., et al. (2004). Addressing the 'risk environment' for injection drug users: The mysterious case of the missing cop. Milbank Quarterly, 82(1), 125-156.
4. Cao, W., & Treloar, C. (2006). Comparison of Needle and Syringe Programme attendees and non-attendees from a high drug using area in Sydney, New South Wales. Drug and Alcohol Review, 25, 439-444.
5. Day, C., Ross, J., & Dolan, K. (2003). Hepatitis C-related discrimination among heroin users in Sydney: Drug user or hepatitis C discrimination? Drug and Alcohol Review, 22, 317-321.
6. Grbich, C. (1999). Qualitative research in health: An introduction. Sydney: Allen & Unwin.
7. Health Outcomes International Pty Ltd, National Centre in HIV Epidemiology and Clinical Research & Drummond, M. (2002). Return on investment in needle and syringe programs in Australia: Summary Report. Canberra, Australia: Commonwealth Department of Health and Ageing.
8. Hofman, N., Strenski, T., Marshall, P., & Heimer, R. (2003). Maintaining respectability and responsibility: Gendered labor patterns among women injection drug users. Healthcare for Women International, 24, 794-807.
9. Hopwood, M., Treloar, C., & Bryant, J. (2006). Hepatitis C and injecting-related discrimination within healthcare in New South Wales, Australia. Drugs: Education, Prevention and Policy, 13, 61-75.
10. Hutchinson, S., Taylor, A., Goldberg, D., & Gruer, L. (2000). Factors associated with injecting risk behaviour among serial community-wide samples of injecting drug users in Glasgow 1990-94: Implications for control and prevention of blood-borne viruses. Addiction, 95, 931-940.
11. Iverson, J., Topp, L., & Maher, L. (2007). Australian NSP Survey. Prevalence of HIV, HCV and injecting and sexual behaviour among IDUs at Needle and Syringe Programs. National Data Report 2002-2006. Sydney, Australia: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales.
12. Lenton, S., & Tan-Quigley, A. (1997). The Fitpack Study: A survey of 'hidden' drug injectors with minimal drug treatment experience. Perth, Australia: National Centre for Research into the Prevention of Drug Abuse, Curtin University of Technology.
13. Maher, L. (1999). Law enforcement and harm minimization in a street-level drug market. British Journal of Criminology, 39(4), 488-512.
14. Matheson, C., Bond, C., & Mollison, J. (1999). Attitudinal factors associated with community pharmacists' involvement in services for drug misusers. Addiction, 94(9), 1349-1359.
15. McCormick, R., Bryant, L., Sheridan, J., & Gonzalez, J. (2006). New Zealand community pharmacist attitudes towards opioid-dependent users. Drugs: Education,. Prevention & Policy, 13(6), 563-575.
16. Montagne, M. (2002). Appreciating the user's perspective: Listening to the 'Methadonians'. Substance Use and Misuse, 37(4), 565-570.
17. NSW Department of Health (2006). Needle and syringe program policy and guidelines for NSW. Sydney, Australia: NSW Department of Health.
18. Patton, M. (2002). Qualitative research and evaluation methods (3rd ed.). Thousand Oaks, CA: Sage.
19. Rich, J., Strong, L., Towe, C., & McKenzie, M. (1999). Obstacles to needle exchange participation in Rhode Island. Journal of Acquired Immune Deficiency Syndromes, 21, 396-400.
20. Sheridan, J., Lovell, S., Turnbull, P., Parsons, J., Stimson, G., & Strang, J. (2000). Pharmacy-based needle exchange (PBNX) schemes in South East England: A survey of service providers. Addiction, 95(10), 1551-1560.
21. Snead, J., Downing, M., Lovrick, J., Garcia, B., Thawley, R., Kegeles, S. M., et al. (2003). Secondary syringe exchange among injection drug users. Journal of Urban Health, 80(2), 330-348.
22. South East Health HIV/AIDS & Related Disease Unit (2003). South East Health Needle and Syringe Program operating policies, procedures & guidelines manual. Sydney, Australia: South East Health.
23. Strathdee, S., Patrick, D., Archibald, C., & Ofner, M. (1997). Social determinants predict needlesharing behaviour among injection drug users in Vancouver, Canada. Addiction, 92, 1339-1347.
24. Thein, H., Denoe, M., van Beek, I., Dore, G., & MacDonald, M. (2003). Injecting behaviour of injecting drug users at needle and syringe programmes and pharmacies in Australia. International Journal of Drug Policy, 14, 425-430.
25. Treloar, C., & Cao, W. (2005). Access to harm reduction services and 'hidden' injectors: Barriers to NSP use in a high drug use area of Sydney, New South Wales. International Journal of Drug Policy, 16, 308-315.
26. Wilkinson, R. (1999). Putting the picture together: Prosperity, redistribution, health and welfare. In M. Marmot & R. Wilkinson (Eds.), Social determinants of health (pp. 256-274). Oxford, UK: Oxford University Press.
27. Wood, E., Tyndall, M., Spittal, P., Li, K., Kerr, T., Hogg, R. S., et al. (2001). Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safe injecting rooms help. Canadian Medical Association Journal, 165, 405-410.
28. Wood, E., Tyndall, M., Spittal, P., Li, K., Hogg, R. S., O'Shaughnessy, M. V., et al. (2002). Needle exchange and difficulty with needle access during an ongoing HIV epidemic. International Journal of Drug Policy, 13, 95-102.